These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9023243)

  • 1. Myringotomized mice develop myringosclerosis in the pars flaccida and not in the pars tensa.
    Mattsson C; Carlsson L; Marklund SL; Hellström S
    Laryngoscope; 1997 Feb; 107(2):200-5. PubMed ID: 9023243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myringosclerosis develops within 9h of myringotomy.
    Mattsson C; Johansson C; Hellström S
    ORL J Otorhinolaryngol Relat Spec; 1999; 61(1):31-6. PubMed ID: 9892867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis.
    Mattsson C; Marklund SL; Hellström S
    Ann Otol Rhinol Laryngol; 1997 Jun; 106(6):513-8. PubMed ID: 9199613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myringotomized tympanic membranes cultured in vitro do not develop myringosclerosis.
    Mattsson C; Berggren D; Hellström S
    Acta Otolaryngol; 2002 Mar; 122(2):168-72. PubMed ID: 11936908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium deposition and expression of bone modelling markers in the tympanic membrane following acute otitis media.
    Raustyte G; Cayé-Thomasen P; Hermansson A; Andersen H; Thomsen J
    Int J Pediatr Otorhinolaryngol; 2006 Mar; 70(3):529-39. PubMed ID: 16159670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane.
    Ozcan C; Görür K; Cinel L; Talas DU; Unal M; Cinel I
    Int J Pediatr Otorhinolaryngol; 2002 May; 63(3):179-84. PubMed ID: 11997152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of caffeic acid phenethyl ester on the prevention of experimentally induced myringosclerosis.
    Song JJ; Kwon SK; Cho CG; Park SW
    Int J Pediatr Otorhinolaryngol; 2007 Aug; 71(8):1287-91. PubMed ID: 17544518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. A study in the rat.
    Spratley JE; Hellström SO; Mattsson CK; Pais-Clemente M
    Ann Otol Rhinol Laryngol; 2001 Jun; 110(6):585-91. PubMed ID: 11407852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of myringosclerosis during acute otitis media caused by Streptococcus pneumoniae and non-typeable Haemophilus influenzae: a clinical otomicroscopical study using the rat model.
    Raustyte G; Hermansson A
    Medicina (Kaunas); 2005; 41(8):661-7. PubMed ID: 16160414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with dexamethasone arrests the development of myringosclerosis after myringotomy.
    Mattsson C; Stierna P; Hellström S
    Am J Otol; 2000 Nov; 21(6):804-8. PubMed ID: 11078067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myringosclerosis caused by increased oxygen concentration in traumatized tympanic membranes. Experimental study.
    Mattsson C; Magnuson K; Hellström S
    Ann Otol Rhinol Laryngol; 1995 Aug; 104(8):625-32. PubMed ID: 7639472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preventive effect of ginkgo biloba extract in myringosclerosis: study in rats.
    Emir H; Kaptan ZK; Samim E; Sungu N; Ceylan K; Ustun H
    Otolaryngol Head Neck Surg; 2009 Feb; 140(2):171-6. PubMed ID: 19201283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of local administration of N-acetylcysteine in perforated rat tympanic membrane: an experimental study in myringosclerosis.
    Ozcan C; Polat G; Görür K; Talas DU; Bağdatoğlu O; Cinel I
    Pharmacol Res; 2002 Jan; 45(1):5-9. PubMed ID: 11820854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myringotomy: a prerequisite for the development of myringosclerosis?
    Mattsson C; Magnuson K; Hellström S
    Laryngoscope; 1998 Jan; 108(1 Pt 1):102-6. PubMed ID: 9432076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a relationship between myringosclerosis and atherosclerosis?
    Selcuk A; Ozlu F; Akdogan O; Ozbek C; Dere H
    B-ENT; 2007; 3(3):127-30. PubMed ID: 17970435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of middle-ear static pressure on pars tensa and pars flaccida of gerbil ears.
    Lee CY; Rosowski JJ
    Hear Res; 2001 Mar; 153(1-2):146-63. PubMed ID: 11223305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long term sequelae of otitis media with effusion during childhood].
    Hassmann-Poznańska E; Goździewski A; Piszcz M; Skotnicka B
    Otolaryngol Pol; 2010; 64(4):234-9. PubMed ID: 20873100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pars flaccida on sound conduction in ears of Mongolian gerbil: acoustic and anatomical measurements.
    Teoh SW; Flandermeyer DT; Rosowski JJ
    Hear Res; 1997 Apr; 106(1-2):39-65. PubMed ID: 9112106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pars tensa and pars flaccida retractions in persistent otitis media with effusion.
    Otol Neurotol; 2001 May; 22(3):291-8. PubMed ID: 11347629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of calcium channel blockers to reduce the progression of experimentally induced myringosclerosis and tympanosclerosis.
    Selcuk A; Akdogan O; Ozcan I; Giray SG; Dere H; Ozogul C
    Laryngoscope; 2008 Apr; 118(4):697-705. PubMed ID: 18176349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.